AI Verdict
IDXX has stronger fundamentals based on our AI analysis.
IDXX vs VRTX Fundamental Comparison
| Metric | IDXX | VRTX |
|---|---|---|
| Revenue | $4.3B | $12.0B |
| Net Income | $1.1B | $4.0B |
| Net Margin | 24.6% | 32.9% |
| ROE | 66.0% | 21.2% |
| ROA | 31.6% | 15.4% |
| Current Ratio | 1.23x | 2.90x |
| Debt/Equity | 0.28x | 0.01x |
| EPS | $13.08 | $15.32 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IDXX vs VRTX: Frequently Asked Questions
Is IDXX or VRTX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IDXX has stronger fundamentals. IDXX is rated STRONG BUY (87% confidence) while VRTX is rated BUY (86% confidence). This is not investment advice.
How does IDXX compare to VRTX fundamentally?
IDEXX LABORATORIES INC /DE has ROE of 66.0% vs VERTEX PHARMACEUTICALS INC / MA's 21.2%. Net margins are 24.6% vs 32.9% respectively.
Which stock pays higher dividends, IDXX or VRTX?
IDXX has a dividend yield of N/A or no dividend while VRTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IDXX or VRTX for long term?
For long-term investing, consider that IDXX has STRONG BUY rating with 87% confidence, while VRTX has BUY rating with 86% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IDXX vs VRTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IDXX vs VRTX, the AI consensus favors IDXX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.